Downregulation of a tumor promotion immune response via induction of oral tolerance towards tumor-associated-antigens: can we 'eat the tumor'?

Medical Hypotheses
I Gotsman, Y Ilan

Abstract

The mechanism by which hepatocellular carcinoma (HCC) develops and the role of the hepatitis B virus (HBV) in inducing tumors, are not yet well understood. Patients persistently infected with HBV tend to have a defective immune response against the virus, which fails to clear the virus and also induces liver injury. This defective response may also have an inducible effect on the virus and on cells that express HBV antigens, as well as play a role in the growth of neoplasm. It is possible that one of the mechanisms of tumor growth is related to a deviant immune response towards viral or tumor associated antigens. We describe two responses against the tumor. A 'good' response that would suppress the tumor and a 'bad' response that would promote it and theorize that the net balance between 'bad' and 'good' responses of the immune system towards a cancerous cell and/or antigen will predict whether a tumor grows or is suppressed. Oral tolerance involves the induction of immunological hyporesponsiveness towards specific antigens. It was shown that oral tolerance induces antigen-specific immune suppression towards tumor-associated-antigens by feeding of HBV or other tumor proteins. We hypothesize that induction of immune tolerance to...Continue Reading

References

Jul 1, 1975·The American Journal of the Medical Sciences·A G Redeker
Aug 1, 1992·Lancet·G M DusheikoA K Burroughs
May 1, 1991·Seminars in Liver Disease·H S MargolisS C Hadler
Jul 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H E BlumJ R Wands
Mar 2, 1990·JAMA : the Journal of the American Medical Association·M J AlterL A Moyer
Jan 1, 1988·Virchows Archiv. A, Pathological Anatomy and Histopathology·D ShouvalD A Shafritz
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·D ShouvalM Sela
May 1, 1985·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D ShouvalJ R Wands
May 1, 1988·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Y F LiawT J Chen
Jan 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K OkudaK Ohnishi
Jan 1, 1995·Annual Review of Immunology·F V Chisari, C Ferrari
Nov 8, 1994·Proceedings of the National Academy of Sciences of the United States of America·H L Weiner
Mar 1, 1994·Annals of Surgery·D G FarmerR W Busuttil
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·L G GuidottiF V Chisari
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A P Venook
Jan 1, 1996·The American Journal of Medicine·M J Koziel
Apr 1, 1996·The Journal of Clinical Investigation·B RehermannF V Chisari
Feb 13, 1996·Annals of the New York Academy of Sciences·Y H Chen, H L Weiner
Jun 1, 1996·The Journal of Experimental Medicine·M F NeurathW Strober
Sep 17, 1998·The Journal of Pediatrics·J R TangM H Chang
Jul 1, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·V Di MarcoA Craxì
Oct 28, 1999·Archives of Pathology & Laboratory Medicine·D H Persing, F G Prendergast
Nov 30, 1999·Immunology Today·U Chattopadhyay
Mar 8, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A NaglerY Ilan

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.